ASO Visual Abstract: Prognostic Benefit of Sequential Locoregional Interventions During First-Line Systemic Therapy for Hepatocellular Carcinoma: Insights from Interaction Analysis of Lenvatinib and Atezolizumab/Bevacizumab.

Authors

Junichi Shindoh, Yusuke Kawamura, Tetsuya Hosaka, Takuma Okada, Satoshi Okubo, Masaru Matsumura, Norio Akuta

Published in

Annals of surgical oncology. Aug 01, 2026. Epub Aug 01, 2026.

PMID:
42542514
Bibliographic data and abstract were imported from PubMed on 02 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.